GALDERMA GETS FDA APPROVAL FOR PSORIASIS SPRAY

The FDA has approved Galderma Laboratories' new drug application for Clobex (clobetasol propionate) Spray for the treatment of moderate-to-severe plaque psoriasis. Clobex Spray is the first clobetasol product available in a non-aerosol spray formulation, the company said.